Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

Abel Noser Solutions and Glue42 Integrate Platforms to Create NextGen Pre-Trade Scenario Builder for Fidessa Users

November 5, 2020
By Abel Noser Solutions;Glue42;
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

NEW YORK, Nov. 5, 2020 /PRNewswire/ — Abel Noser Solutions, an industry-leading provider of TCA and compliance analytics has partnered with Glue42, a European-based systems integrator of cutting edge trading desktop functionalities to provide mutual clients significant enhancements to already robust workflow options.  The new Pre-Trade Scenario Builder provides single click integration to major OMS platforms starting with Fidessa. The combined effort of Glue42 and ANS will provide key, in-the-moment execution consulting for traders and their clients.

“Once installed, traders can click on any ticker symbol to generate an Abel Noser powered empirical and theoretical  pre-trade analysis which, among other things, produces a typical distribution of trade costs in basis points,” commented Peter Weiler, Co-CEO of Abel Noser. “Moreover, one can drill down for more detail, allowing you to change share amounts and other attributes, producing outcome scenarios based on the inputs,” Mr. Weiler added.

“We welcome this partnership with Abel Noser Solutions. Glue42 enables the Pre-Trade Scenario Builder to become quickly and seamlessly integrated within the trader’s existing workflow,” said Leslie Spiro, CEO of Glue42. “The integration allows the Scenario Builder to extend the value of an OMS and other desktop applications, providing key projections needed to make in-the-flow trading decisions.”

The scenario engine presents a pre-trade look at a trade as well as providing key metrics for consideration such as average daily volume (ADV), average shares per trade, what the average open volume is, and how many trades-per-minute occur. Mike Earlywine, SVP of Channel Partnerships at Abel Noser Solutions added, “There’s also a slider that allows you to change the percentage of ADV.  Since it shares workspace with the Fidessa blotter, traders can avoid typical swivel chair workflow obstacles; everything is integrated for efficiency and convenience.”

The integration allows traders to consider the projected friction to trade relative to the size and aggressiveness of a scenario. Costs can be calculated whether the single stock trade or portfolio trade is 50,000 or 5 million shares. James Wooster, Glue42’s COO, echoed the synergistic value of the partnership. “The Pre-Trade Scenario Builder offers an intuitive user experience where critical data is surfaced and synchronized between our two companies’ applications in real-time.”

About Abel Noser Solutions  
Abel Noser Solutions has long been respected as a leader in the campaign to lower the costs associated with multi-asset trading. With hundreds of clients worldwide, Abel Noser Solutions offers innovative software products along with consultative and bespoke services in the areas of trade analytics, compliance, and trade surveillance. The firm continues to hold its place as the leading innovator in TCA, compliance software, and service solutions. Learn more at www.abelnoser.com.

About Glue42
Glue42 enables organizations to build intelligent desktops that support configurable workflows between web and desktop applications. Its integration platform seamlessly and securely orchestrates UI and data and leverages opensource initiatives such as FINOS FDC3 to reduce application delivery times and accelerate time to value. The company is based in London, New York and Bulgaria. With over 22K licenses, its solutions are deployed at tier-one financial institutions across the world.

Media Contact:
Jerry Boak
Abel Noser Holdings
info@abelnoser.com
(646) 432-4000

 

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

9:40 Future Import Test

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

Test New Article 12092025 - 2 - Closing

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
Powered byBLOX Digital
X